Moleculin Biotech, Inc. (MBRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.92M |
| Enterprise Value | -4.6M |
| P/E Ratio | -0.02 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.14 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.03 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.44 |
| Return On Equity | -8.17 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -90,000 |
| EBITDA | -33.47M |
| Net Income | -33.56M |
| Diluted EPS | -568.4 |
Balance Sheet
| Total Cash | 7.26M |
| Total Cash/Share | 25.57 |
| Total Debt | 292,000 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 0.94 |
| Book Value Per Share | 40.79 |
Price History
| 52-Week Change | -97.36 |
| 52-Week High | 315 |
| 52-Week Low | 3.22 |
| Moving Average 50 Days | 11.4 |
| Moving Average 200 Days | 42.99 |
Statistics
| Average Volume | 69,010 |
| Shares Outstanding | 1.02M |
| % Held by Institutions | 3.27 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.06 |
| Last Split Factor | 1:20 |
| Last Split Date | October 20, 2026 |
AD
